Form 4: Boundless Bio Insiders Report Stock Transactions

Several directors and 10% owners of Boundless Bio, Inc. have reported transactions involving common stock and stock options.

Summary

• Several individuals, including directors and 10% owners of Boundless Bio, Inc., have filed Form 4 statements detailing changes in their beneficial ownership of the company's common stock.
• These transactions include the acquisition of common stock via cashless stock option exercises and the disposal of common stock.
• The reporting persons are associated with ARCH Venture Funds and have disclosed various forms of indirect beneficial ownership through limited partnerships and limited liability companies.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports both acquisitions and disposals of stock by insiders, which is typical activity for venture capital-backed entities and their representatives.

Positives

• Kristina Burow exercised a stock option, acquiring 16,000 shares of common stock at $1.03 per share.
• The stock option exercised by Kristina Burow was granted in connection with her board service and vested over time, with the final portion vesting on June 15, 2026.

Negatives

• Keith Crandell, Clinton Bybee, Robert Nelsen, Steven Gillis, and Kristina Burow (all directors and/or 10% owners) disposed of a total of 16,000 shares of common stock at $2.49 per share.

Risks

• The filing does not explicitly mention any current issues or potential future challenges.

Future Outlook

No specific forward-looking statements or guidance are provided in this Form 4 filing.

Management Comments

• The filing includes remarks indicating that this Form 4 is one of two reports relating to the same transaction being filed jointly by multiple reporting persons.
• Signatures are provided by each reporting person or their attorney-in-fact, indicating the transactions and ownership details.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the buying and selling activities of company executives and major shareholders. These filings are crucial for investors seeking to understand insider sentiment and potential shifts in beneficial ownership.

Related Party Transactions

• The filing details transactions involving individuals associated with ARCH Venture Funds, including limited partnerships and limited liability companies, which represent related parties in the context of venture capital investment.

Stakeholder Impact

• Shareholders may interpret the disposal of shares by insiders as a signal, though in this context, it is likely related to venture capital fund management and option exercises rather than a negative outlook on the company's future.

Next Steps

• Continued monitoring of insider transactions for Boundless Bio, Inc. to observe any further changes in beneficial ownership.

Key Dates

Keywords

Form 4, SEC Filing, Boundless Bio, BOLD, Stock Options, Beneficial Ownership, Insider Trading, Venture Capital, ARCH Venture Fund